Medications

Pharma's niche focus spurs US aid for antibiotics

(AP) -- The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new treatments for diseases ...

Diseases, Conditions, Syndromes

Pirfenidone: Extent of added benefit assessed

Pirfenidone inhibits the development of inflammation and scarring (fibrosis) in pulmonary tissue and has been approved for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) since the beginning of 2011. ...

page 3 from 3